Centogene N.V.
CNTG · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $49 | $47 | $42 | $38 |
| % Growth | 2.2% | 12.4% | 9.8% | – |
| Cost of Goods Sold | $31 | $28 | $28 | $35 |
| Gross Profit | $17 | $20 | $15 | $3 |
| % Margin | 35.5% | 42% | 34.5% | 8.2% |
| R&D Expenses | $12 | $17 | $19 | $15 |
| G&A Expenses | $29 | $29 | $43 | $38 |
| SG&A Expenses | $42 | $39 | $53 | $45 |
| Sales & Mktg Exp. | $13 | $10 | $9 | $8 |
| Other Operating Expenses | -$7 | -$0 | $0 | $0 |
| Operating Expenses | $47 | $57 | $73 | $60 |
| Operating Income | -$30 | -$37 | -$55 | -$54 |
| % Margin | -61.1% | -77.5% | -131.4% | -139.7% |
| Other Income/Exp. Net | -$6 | -$2 | -$2 | -$6 |
| Pre-Tax Income | -$35 | -$39 | -$57 | -$60 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$36 | -$32 | -$46 | -$21 |
| % Margin | -73.2% | -67.1% | -109.5% | -55.6% |
| EPS | -1.27 | -1.11 | -2.09 | -1.02 |
| % Growth | -14.4% | 46.9% | -104.9% | – |
| EPS Diluted | -1.26 | -1.11 | -2.09 | -1.02 |
| Weighted Avg Shares Out | 28 | 27 | 22 | 21 |
| Weighted Avg Shares Out Dil | 28 | 27 | 22 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $4 | $1 | $1 |
| Depreciation & Amortization | $8 | $10 | $20 | $15 |
| EBITDA | -$19 | -$25 | -$37 | -$44 |
| % Margin | -40% | -51.9% | -86.8% | -113.6% |